newsfilter
← Latest News
GlobeNewswire·

C4 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Cemsidomide’s Ongoing Phase 2 MOMENTUM Trial and Phase 1b Trial in Combination With Elranatamab Remain on Track to Deliver Clinical Data Readouts in 2027 Phase 1 Data Presented at European Hematology Association (EHA)